Page URL:

Rheumatoid arthritis: largest study yet yields risk gene haul

6 January 2014
Appeared in BioNews 736

The largest genetic study of rheumatoid arthritis (RA) to date has found an additional 42 disease-associated locations in the genome. Published in Nature, the authors claim that these sites might offer insights in repurposing existing drugs to treat RA.

Researchers from institutions across seven countries analysed genetic data from 100,000 people – 29 percent with RA and 71 percent healthy controls – looking at ten million different genetic sites in each. By comparing the healthy DNA against those with RA, the authors could see whether any particular genetic difference is associated with the disease.

Each of these sites, or SNPs (single nucleotide polymorphisms), is a particular location in our DNA that is known to differ between people by one 'letter' or base. By looking at which genes the disease-associated SNPs occur in or near to, it might be possible to find biological processes that contribute towards diseases.

Beyond the traditional genome-wide association studies (GWAS) used to measure SNPs, this study used a number of different laboratory and data-mining experiments to get extra information from their genetic data.

In addition to finding the 42 RA-associated SNPs (bringing the total of such known 'risk' sites up to 101), this study aimed to use these novel techniques to use the genetic data as a resource to find known drugs which might be useful for treating RA.

The researchers used a database of drug targets to find a list of genes for which there is an approved or experimental drug that targets the protein that the gene encodes. This list was then compared to the list of genes that the RA risk-SNPs occur close to, along with genes that they interact with.

This analysis produced 27 genes that are already the targets of existing RA drugs, which suggests that these genetic techniques are indeed able to find suitable genes to target therapeutically. Furthermore, other genes which are targeted by drugs used to treat other diseases were also revealed, including a number of anti-cancer drugs, raising the possibility these drugs might also be useful in treating RA.

'This [study] almost doubles the number of previously-known risk regions and adds a significant amount to the current knowledge and understanding of the genetic basis of this condition', said Professor Alan Silman, medical director of Arthritis Research UK.

'In addition, the results of this work have identified similarities with some other conditions which suggests that evaluation of existing treatments could be beneficial and may lead to new and improved therapies for the half a million people currently living with rheumatoid arthritis'.

'Faulty' DNA discovery could point to cure for arthritis
Independent |  25 December 2013
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Nature |  25 December 2013
Huge Gene Study Boosts New Drug Hopes for Rheumatoid Arthritis
Genetic Engineering and Biotechnology News |  26 December 2013
New genetic clues for rheumatoid arthritis 'cure'
BBC News |  25 December 2013
Over 100 genetic risk markers for rheumatoid arthritis identified
University of Manchester |  26 December 2013
18 March 2013 - by Reuben Harwood 
An experimental gene therapy that protects cartilage from wear and deterioration has been shown to slow the development of osteoarthritis in mice....
16 July 2012 - by Dr Greg Ball 
Two UK newspapers have hailed a potential treatment for osteoarthritis using a patient's own stem cells although results from early studies in animals and patients are yet to be published...
18 July 2011 - by Sarah Pritchard 
A team of international researchers have identified several new genetic variants that are involved in a type of incurable spine arthritis – ankylosing spondylitis (AS) – offering hope for novel treatments for those with the condition...
21 June 2010 - by Louise Mallon 
A recent study has shown a rare genetic mutation in a single gene is linked to several different autoimmune diseases, including Type 1 diabetes, lupus and rheumatoid arthritis...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.